Pennrose filed plans for an adaptive reuse of a former church in Jamaica Plain that would turn the property into 55 housing units and a performance space.
11.04.2022 - At the AACR Annual Meeting 2022, Bruker Corporation (Nasdaq: BRKR) launched and exhibited unique and novel capabilities for spatial multiomics, single-cell proteomics, and cell-line, tissue and plasma proteomics cancer research. This press release .
Transforming Multiomics Spatial Tissue Biology with the Power of MALDI Mass Spectrometry for Imaging Targeted Proteins, Lipids, Glycans and Metabolites
Transforming Multiomics Spatial Tissue Biology with the Power of MALDI Mass Spectrometry for Imaging Targeted Proteins, Lipids, Glycans and MetabolitesWATERTOWN, Mass. (BUSINESS WIRE) Boston-area life science technology company AmberGen Inc. today announced that it has closed a strategic investment by Bruker Corpo.